Pharmacokinetics of indinavir combined with low-dose ritonavir in human immunodeficiency virus type 1-infected children

Autor: R. de Groot, A. M. C. van Rossum, David M. Burger, R. Y. Leavitt, Bach-Yen Nguyen, L. H. Wynne, G. Verweel, Pieter L. A. Fraaij, Alina S. Bergshoeff, Gregory A. Winchell

Publikováno v: Antimicrobial Agents & Chemotherapy, 48(5), 1904-1907. American Society for Microbiology
Antimicrobial Agents and Chemotherapy, 48, 1904-7
Antimicrobial Agents and Chemotherapy, 48, 5, pp. 1904-7

Contains fulltext : 58632.pdf (Publisher’s version ) (Closed access) So far, no pediatric doses for indinavir combined with ritonavir have been defined. This study evaluated the pharmacokinetics of 400 mg of indinavir/m(2) combined with 125 mg of r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc3670f7f53dbbb9c4b56b5d1d0bac8f
https://doi.org/10.1128/AAC.48.5.1904-1907.2004

Limited Prognostic Value of Changes in Antineutrophil Cytoplasmic Antibody Titers in Patients with Wegener’s Granulomatosis

Autor: Gail S. Kerr, C W Hallahan, Gary S. Hoffman, R. Y. Leavitt, Thomas A. Fleisher, Anthony S. Fauci

Publikováno v: Advances in Experimental Medicine and Biology ISBN: 9781475791846

One hundred and six patients with Wegener's granulomatosis (WG) were studied for the presence of antineutrophil cytoplasmic antibodies (ANCA). In 53 patients serial ANCA determinations were obtained. C-ANCA positivity was a sensitive (88%) marker of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::21044da9ae94d0827ba1da50821d4ea5
https://doi.org/10.1007/978-1-4757-9182-2_71

The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate

Autor: G S, Hoffman, R Y, Leavitt, G S, Kerr, A S, Fauci

Publikováno v: Arthritis and rheumatism. 35(11)

To identify alternatives to daily low-dose cyclophosphamide (CYC) in the treatment of Wegener's granulomatosis (WG).An open-label pilot study of weekly low-dose methotrexate (MTX) plus glucocorticoids (GC) for treatment of patients with WG was perfor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9ef68db426d6c30105ab06df369eb296
https://pubmed.ncbi.nlm.nih.gov/1445449

Infectious complications of cyclophosphamide treatment for vasculitis

Autor: G S, Hoffman, R Y, Leavitt, A S, Fauci

Publikováno v: Arthritis and rheumatism. 32(12)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5d532d76f7e3bfd9ee432514d8a2f243
https://pubmed.ncbi.nlm.nih.gov/2563226

Polyangiitis overlap syndrome. Classification and prospective clinical experience

Autor: R Y, Leavitt, A S, Fauci

Publikováno v: The American journal of medicine. 81(1)

Ten patients were prospectively studied who had features of systemic vasculitis that could not be classified into one of the well-defined vasculitic syndromes. Since many of these syndromes had overlapping features of several distinct vasculitides, t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1edf07e65a30e6b8d752cd84f73b82e8
https://pubmed.ncbi.nlm.nih.gov/2873744